3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Oxaliplatin
21
Capecitabine
19
Fluorouracil
16
Bevacizumab
16
Esomeprazole
11
Sorafenib
10
Irinotecan
9
Leucovorin
8
Radiofrequency Ablation
7
Propofol
7
Bismuth
7
Morphine
6
Gemcitabine
6
Folfox protocol
6
Amoxicillin
6
lenvatinib
5
gadolinium ethoxybenzyl DTPA
5
Tetracycline
5
Sevoflurane
5
S 1 (combination)
5
Drug Therapy
5
Control Groups
5
Cisplatin
5
sodium glycididazole
4
fish oil triglycerides
4
ferric carboxymaltose
4
Sodium Chloride
4
Ropivacaine
4
Ribavirin
4
Hepatectomy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Patient-Specific Modeling
×
Gastrointestinal
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn